Manel Juan

54PUBLICATIONS
370CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Sep 03, 2026
Chimeric HLA Antibody Receptor (CHAR) T Cells to Specifically Eliminate HLA-DQ-Specific B Cells.

|Jul 24, 2026
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.

|Jul 22, 2026
CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma.

|Apr 24, 2026
IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.

|Mar 30, 2026
Antagonistic SMAD2/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancer.

Natalia Díaz-Valdivia, Paula Duch, Rafael Ikemori

|Mar 03, 2026
Enhanced antitumoral activity of the academic CAR-T ARI0002h against normal and low BCMA-expressing myeloma cells after incorporating a transmembrane CD28 domain.

Oriol Cardus, Joan Mañé Pujol, Anna de Daniel

Pageof 9

Frequent Collaborators

10 joint publications

Valentín Ortiz-Maldonado

9 joint publications

Julio Delgado

9 joint publications

Carlos Fernández de Larrea

8 joint publications

Beatriz Martín-Antonio